Myocardial Ischemia News

Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene ... - MarketWatch (press release)



Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene ... 
MarketWatch (press release)
In addition, Dr. Rubanyi will also make an oral presentation titled: "New Perspectives for Angiogenic Gene Therapy to Treat Myocardial Ischemia in Patients with Coronary Disease" to attendees at the ASGCT Meeting today, May 16.

and more » 


'Virtual Stenting' Aids PCI Planning - MedPage Today



'Virtual Stenting' Aids PCI Planning 
MedPage Today
This study suggests that CT-derived computed fractional flow reserve estimation along with CT-derived virtual stent placement can accurately predict the success of intervention in relieving myocardial ischemia. PARIS -- Computer projections of the ...
EuroPCR 2012 press release for Wednesday, May 16, 2012 Phys.Org (press release)

all 7 news articles » 


Cardium Presents First Quarter 2012 Financial Results and Recent Developments - MarketWatch (press release)



Proactive Investors UK 
Cardium Presents First Quarter 2012 Financial Results and Recent Developments 
MarketWatch (press release)
During first quarter 2012, Cardium announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of its lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia due to coronary artery ...
Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen ... Healthcare Global (press release)

all 16 news articles » 


Lantheus Medical Imaging Announces Manufacturing and Supply Agreements with ... - MarketWatch (press release)



Lantheus Medical Imaging Announces Manufacturing and Supply Agreements with ... 
MarketWatch (press release)
Cardiolite(R) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction ...

and more » 


Fractional Flow in Focus at EuroPCR - MedPage Today



Fractional Flow in Focus at EuroPCR 
MedPage Today
By Crystal Phend, Senior Staff Writer, MedPage Today PARIS -- Ischemia-guided therapy for multivessel coronary artery disease interventions may be the show-stealer at this year's EuroPCR meeting here. "There's going to be a lot of focus on ...

 


Stress Echo After PCI, CABG Questioned - MedPage Today



Stress Echo After PCI, CABG Questioned 
MedPage Today
The authors found that 40% of the patients had a history of myocardial infarction (MI), that 1143 had undergone PCI, and that 962 had undergone CABG. The time since revascularization averaged 4.1 years. Exercise echocardiography detected ischemia in ...
Study examines exercise testing in asymptomatic patients after coronary ... Science Codex

all 18 news articles » 


Medicure Announces Commencement of Enrollment in SAVI-PCI Trial of AGGRASTAT - MarketWatch (press release)



Medicure Announces Commencement of Enrollment in SAVI-PCI Trial of AGGRASTAT 
MarketWatch (press release)
In this setting, AGGRASTAT has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure. AGGRASTAT has been studied in a setting that included aspirin and heparin.

and more » 


Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of ... - MarketWatch (press release)



Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of ... 
MarketWatch (press release)
Cardiac ischemia and/or myocardial infarction may occur. Temporary or permanent discontinuation of Nexavar should be considered in patients who develop cardiac ischemia and/or myocardial infarction. Gastrointestinal perforation was an uncommon adverse ...

and more » 


5 Reasons To Buy NeoStem And 2 Catalysts - Seeking Alpha



5 Reasons To Buy NeoStem And 2 Catalysts 
Seeking Alpha
AMR-001 works by increasing microvascular blood flow in the myocardium via neoangiogenesis, thereby reversing post-infarct ischemia and rescuing tissue from hibernation and preventing eventual death (apoptosis). There was a story on myFOXOrlando on ...

and more » 


Ixmyelocel-T cell therapy may help DCM patients - TheHeart.Org



Ixmyelocel-T cell therapy may help DCM patients 
TheHeart.Org
In the treatment group, the cells were injected into the myocardium. There were no procedural complications and no difference in adverse events, including arrhythmias, in the treatment vs control groups, but ischemic ixmyelocel-T-treated patients had ...

and more »